Faster, Please!

Faster, Please!

Share this post

Faster, Please!
Faster, Please!
⤴⤵ Up Wing/Down Wing #7

⤴⤵ Up Wing/Down Wing #7

A curated selection of pro-progress and anti-progress news items from the week that was

James Pethokoukis's avatar
James Pethokoukis
Jun 15, 2024
∙ Paid
7

Share this post

Faster, Please!
Faster, Please!
⤴⤵ Up Wing/Down Wing #7
1
Share
A scene with two distinct paths diverging in a surreal landscape. On the left, the path leads to a dark, nightmare dystopia with decaying buildings, dead trees, and a gloomy, overcast sky. The atmosphere is eerie and foreboding, with shadows and twisted, barren terrain. On the right, the path leads to a bright, futuristic utopia with sleek, modern architecture, lush green parks, and a clear, sunny sky. The atmosphere is vibrant and welcoming, with advanced technology and thriving nature. The contrast between the two paths is stark and dramatic.

Up Wing Things

⚡ The most advanced nuclear facility in the world is under construction in Kemmerer, Wyoming. TerraPower, a company initially founded by Bill Gates, has broken ground for a new nuclear power plant whose design boasts stronger safety measures with more consistent temperatures than any existing plant. Gates says that the NRC has accepted the construction permit application, and in the meantime, the company will continue to build the non-nuclear parts of the plant. He hopes to begin construction on the nuclear aspect in 2026.

Gates:

The design was far safer than any existing plant, with the temperatures held under control by the laws of physics instead of human operators who can make mistakes. It would have a shorter construction timeline and be cheaper to operate. And it would be reliable, providing dependable power throughout the day and night. As I looked at the plans for this new reactor, I saw how rethinking nuclear power could overcome the barriers that had hindered it—and revolutionize how we generate power in the U.S. and around the world. (GatesNotes)

⚕️ The effort to treat Alzheimer’s has made a step in the right direction. An FDA committee  met Monday to discuss donanemab, which has shown promising results in delaying the symptoms of dementia. The drug targets the protein amyloid, which, at abnormal levels, can disrupt cell function. Once amyloid is reduced, patients can experience another few months of clear thinking. The disease is still too complex to be cured by one drug, but the use of donanemab represents progress and is worth pursuing as a treatment. (WSJ Opinion)

Keep reading with a 7-day free trial

Subscribe to Faster, Please! to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 James Pethokoukis
Publisher Privacy ∙ Publisher Terms
Substack
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share